I think the price/volume are interesting this morning. Are these existing shareholders fortifying their positions, or long time followers finally getting on the bandwagon after seeing 2 more NYPres patients injected -- or maybe individuals somehow connected to the hospital and/or its staff reacting to leronlimab's efficacy.

I don't want to sound like a conspiracy theorist, and we are all painfully aware of historical intraday price fluctuations. But, I have been operating on the assumption that when good things really started happening with those patients -- we were likely going to see unexplained price/volume increases.

Of course, I am probably wrong and we could easily be well below $1 later today.

I just find it interesting to watch and consider the few visible external signposts that we have that can give us an idea of what's going on in that hospital.